Abstract

Neuroprotective, anti-inflammatory, and remyelinating properties of androgens are well-characterized in demyelinated male mice and men suffering from multiple sclerosis. However, androgen effects mediated by the androgen receptor (AR), have been only poorly studied in females who make low androgen levels. Here, we show a predominant microglial AR expression in demyelinated lesions from female mice and women with multiple sclerosis, but virtually undetectable AR expression in lesions from male animals and men with multiple sclerosis. In female mice, androgens and estrogens act in a synergistic way while androgens drive microglia response towards regeneration. Transcriptomic comparisons of demyelinated mouse spinal cords indicate that, regardless of the sex, androgens up-regulate genes related to neuronal function integrity and myelin production. Depending on the sex, androgens down-regulate genes related to the immune system in females and lipid catabolism in males. Thus, androgens are required for proper myelin regeneration in females and therapeutic approaches of demyelinating diseases need to consider male-female differences.

Androgen effects have been poorly studied in demyelinating diseases in females. Here, authors show androgen requirement for proper myelin regeneration in females and the critical need to consider male-female differences in multiple sclerosis patients.

Details

Title
Androgens show sex-dependent differences in myelination in immune and non-immune murine models of CNS demyelination
Author
Zahaf, Amina 1 ; Kassoussi, Abdelmoumen 1 ; Hutteau-Hamel, Tom 2 ; Mellouk, Amine 2 ; Marie, Corentine 3 ; Zoupi, Lida 4   VIAFID ORCID Logo  ; Tsouki, Foteini 4   VIAFID ORCID Logo  ; Mattern, Claudia 5 ; Bobé, Pierre 2 ; Schumacher, Michael 1   VIAFID ORCID Logo  ; Williams, Anna 4   VIAFID ORCID Logo  ; Parras, Carlos 3   VIAFID ORCID Logo  ; Traiffort, Elisabeth 1   VIAFID ORCID Logo 

 U1195 Inserm, Paris-Saclay University, Kremlin-Bicêtre, France (GRID:grid.460789.4) (ISNI:0000 0004 4910 6535) 
 UMR996 Inserm, Paris-Saclay University, Clamart, France (GRID:grid.460789.4) (ISNI:0000 0004 4910 6535) 
 Paris Brain Institute, Sorbonne University, Paris, France (GRID:grid.425274.2) (ISNI:0000 0004 0620 5939) 
 The University of Edinburgh, Edinburgh BioQuarter, Centre for Regenerative Medicine, Institute for Regeneration and Repair, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988) 
 M et P Pharma AG, Emmetten, Switzerland (GRID:grid.4305.2) 
Pages
1592
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2789593009
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.